UK’s NICE Says ‘Light Touch’ HTA Evaluation Will Support Innovation
The UK’s health technology assessment body recognizes that its traditional product evaluation processes are too slow for innovative medtech products. Its new “conditional recommendation” pathway aims to fix this.
You may also be interested in...
UTIs are one of the most common reasons for antibiotics to be prescribed, but accurate and timely diagnostic tools are lacking. England’s NICE has identified four innovative IVDs that could be rolled out for NHS patients, but said more research is needed on these products first.
Five digital mental health apps for children with low mood and anxiety are set to receive interim reimbursement via the UK’s early value assessment (EVA) pilot in a bid to tackle staff shortages and long waiting times for current interventions.
NICE, the body that produces health technology assessment guidance for England and Wales, has earlier this month introduced updates to its evidence standards guidance for developers of digital technologies based on artificial intelligence (AI) and on adaptive algorithms.